Fecal transplant for C. diff and ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether one or multiple fecal transplants from a healthy donor can help treat both a recurring C. diff infection and active ulcerative colitis. It aims to find the best schedule for the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have active ulcerative colitis.
- You have a C. diff infection that keeps coming back.
- You are able to give informed consent.
- Your doctor has recommended fecal microbiota transplant for your recurring C. diff infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study looks at how fecal microbiota transplantation (FMT) affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. diff infection. It aims to understand how the donor bacteria settle in the gut.
This early-stage study tests whether a one-time transfer of “donor gut bacteria” can improve ulcerative colitis. It’s designed for people with mild to moderate ulcerative colitis who are stable on maintenance treatment.
Hear when a new Clostridium Difficile trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.